Prevalence of polycystic ovary syndrome (<scp>PCOS</scp>) among reproductive age women from Kashmir valley: A cross‐sectional study

Ganie, Mohd Ashraf; Rashid, Aafia; Sahu, Danendra; Nisar, Shazia; Wani, Idrees Ahmed; Khan, Junaida

doi:10.1002/ijgo.13125

Cited by 48 publications

(31 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Where as in study by Sachdeva G et al it was 67.7%, 11%, 17.7% and 3.6% respectively [15] . Mean age at menarche in women with PCOS in this study was 13.3 years and was slightly high compared with women without PCOS similar to study by Ganie et al (13.1years) [16] . Oligomenorrhoea was seen in 24.5% of women in this study and was statistically high in women with PCOS (84.7%) which was high compared with study by Ramanand SJ et al where oligomenorrhoea seen in 65% of women with PCOS [5] .…”

Section: Discussionsupporting

confidence: 88%

“…Clinical hyperandrogenism in this study was seen in 63.9% of PCOS women, whereas in study by Ramanand et al it was present in 51.7% of women with PCOS [5] . FSH and LH in present study was 8.1±1.4 and 16.2±2.4 which is slightly high compared with study by Ganie et al it was 6.67 ± 2.14 7 and 8.23 ± 4.99 respectively [16] . Biochemical hyperandrogenism was seen in 94.4% of women with PCOS in this study which was low compared with study by Lauristen et al (51.5%) [8] FAI was high in PCOS women in this study similar to study by Joshi et al [14] As per BMI, the prevalence of obesity and overweight in our study group together was 61.1% in patients with PCOS which was lower when compared with study by Abid K et al it was 27% and 53%, respectively.…”

Section: Discussioncontrasting

confidence: 61%

See 1 more Smart Citation

A cross sectional study on, prevalence of polycystic ovarian syndrome and its health effects, in reproductive age women (15-45 years) in a rural area, Telangana, India

Kusuma¹,

Anusha²,

Jagannivas³

et al. 2021

Int. J. Clin. Obstet. Gynaecol.

View full text Add to dashboard Cite

Introduction: Polycystic Ovary Syndrome causes irregular menstrual cycles, excessive body or facial hair and polycystic ovaries. Prevalence ranges from 2.2% to 26% globally, as it is not defined precisely. This is a community based study in the reproductive age women (15-45years) to correctly assess prevalence of PCOS and health effects in women with PCOS. Material and Methods: Cross sectional study done in 624 Reproductive age women (15-45 years) in a rural area. Data collected by interview method, clinical examination of which 182 women (with signs suggestive of PCOS) got biochemical and ultrasound to establish diagnosis of PCOS and health effects were studied. Data analysed using SPSS 20. Results: Prevalence of PCOS was 72(11.5%). Infertility followed by psychosocial problems was the most common health effects. Conclusion:Although infertility was seen in 73.6% of women with PCOS, only 18% received treatment in the past, due to under diagnosis and lack of accessibility.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Discussioncontrasting

confidence: 61%

A cross sectional study on, prevalence of polycystic ovarian syndrome and its health effects, in reproductive age women (15-45 years) in a rural area, Telangana, India

Kusuma¹,

Anusha²,

Jagannivas³

et al. 2021

Int. J. Clin. Obstet. Gynaecol.

View full text Add to dashboard Cite

show abstract

“…Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women in their reproductive age and the prevalence of this syndrome varies from 6.5 to 19.9% in the world [ 1 , 2 ]. According to the latest systematic review studies, the prevalence of this syndrome is estimated at 3% according to the definition provided by the National Institutes of Health (NIH) and at 7% according to the definition provided by Rotterdam in Iran [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

“…Infertility is considered as one of the most common problems in human societies which has affected between 60 and 80 million couples worldwide according to the World Health Organization reports [ 5 ]. The prevalence of infertility in Iran is reported to be about 7.88% [ 2 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

“…Polycystic ovary syndrome can increase androgen level (sings such as acne, hirsutism, and alopecia) and nonovulatory characteristics (such as oligomenorrhea, amenorrhea, or infertility) [ 2 ]. Diagnostic criteria for this syndrome include lack of ovulation, clinical or laboratory hyperandrogenism, or observation of polycystic ovaries on ultrasound [ 6 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Yoga Effects on Anthropometric Indices and Polycystic Ovary Syndrome Symptoms in Women Undergoing Infertility Treatment: A Randomized Controlled Clinical Trial

Mohseni

Eghbali

Bahrami

et al. 2021

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

The aim of this study was to investigate the effects of yoga exercises on anthropometric parameter and clinical sign of PCOS among women undergoing infertility treatment. This clinical trial study was performed on 61 women with PCOS who have undergone infertility treatment at Sarem Hospital in Tehran, Iran. The patients were first selecting based on purposeful and then randomly assigning to the intervention and control groups. In the intervention group, yoga exercises were performed for 6 weeks and the patients in the control group only received routine care. Anthropometric parameters and clinical signs were performed and recorded. After the intervention, here was a significant reduction in hirsutism, abdominal circumference, and hip circumference scores in the intervention group compared to the control group ( P < 0.05 ). Given the effects of yoga exercises on the improvement of hirsutism, abdominal circumference, and hip circumference, it is suggested to use yoga as a treatment strategy in women with PCOS.

show abstract

Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women

Ganie,

Chowdhury,

Malhotra

et al. 2024

JAMA Netw Open

View full text Add to dashboard Cite

ImportanceThe prevalence of polycystic ovary syndrome (PCOS) varies across the globe. Indian studies on PCOS are limited by poor design, small sizes, regional representations, and varying methods.ObjectivesTo estimate the nationwide prevalence of PCOS in India, examine the phenotypic spectrum, and assess the magnitude of comorbidities associated with PCOS.Design, Setting, and ParticipantsThis cross-sectional study recruited 9824 women aged 18 to 40 years from November 1, 2018, to July 31, 2022, across 5 zones of the country. A prevalidated questionnaire dichotomized women into screen-positive and screen-negative groups. Relevant clinical, hormonal, and sonographic assessments categorized women as either women with criteria-based PCOS (ie, National Institutes of Health [NIH] 1990 criteria, Rotterdam 2003 criteria, or Androgen Excess and Polycystic Ovary Syndrome Society [AE-PCOS] criteria), women with partial phenotypes (hyperandrogenism, oligomenorrhea, or polycystic morphology labeled as pre-PCOS), or healthy women, in addition to quantitating various comorbidities.Main Outcomes and MeasuresThe prevalence and phenotypes of PCOS among women of reproductive age and the burden of comorbidities associated with PCOS.ResultsA total of 8993 women (mean [SD] age, 29.5 [6.2] years) were enrolled in this study; 196 women were already diagnosed with PCOS, 2251 were categorized as screen positive, and 6546 were categorized as screen negative. The mean (SD) age of screen-positive women (28.1 [6.4] years) was lower than that of screen-negative women (29.7 [6.1] years) (P &lt; .001), and the mean (SD) age at menarche was higher in the former group (13.2 [1.3] vs 13.1 [1.2] years; P &lt; .001). The national prevalence of PCOS was 7.2% (95% CI, 4.8%-10.8%) by NIH 1990 criteria, 19.6% (95% CI, 12.7%-29.2%) by Rotterdam 2003 criteria, and 13.6% (95% CI, 8.4%-21.6%) by AE-PCOS criteria. Overall, PCOS phenotypes C (501 [40.8%]) and D (301 [24.6%]) were the most common, and 492 women (pre-PCOS subgroup) had oligomenorrhea (n = 75), hyperandrogenism (n = 257), or polycystic ovarian morphology (n = 160) only. Among women with PCOS (n = 1224), obesity was present in 529 (43.2%), dyslipidemia in 1126 (91.9%), nonalcoholic fatty liver disease in 403 (32.9%), metabolic syndrome in 305 (24.9%), impaired glucose tolerance in 111 (9.1%), diabetes in 41 (3.3%), and hypertension in 101 (8.3%). The pre-PCOS subgroup (n = 492) displayed similar metabolic aberrations (dyslipidemia: 390 [79.3%]; metabolic syndrome: 78 [15.9%]; nonalcoholic fatty liver disease: 163 [33.1%]; impaired glucose tolerance: 62 [12.6%]; diabetes: 7 [1.4%]; and hypertension: 26 [5.3%]).Conclusions and RelevanceIn this cross-sectional study of reproductive-age women recruited across India, the prevalence of PCOS was high, with phenotype C being predominant. Most of these women had metabolic abnormalities. These findings are crucial for developing preventive and therapeutic strategies, potentially integrating PCOS management into national health programs.

show abstract

Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross‐sectional study

Cited by 48 publications

References 23 publications

A cross sectional study on, prevalence of polycystic ovarian syndrome and its health effects, in reproductive age women (15-45 years) in a rural area, Telangana, India

A cross sectional study on, prevalence of polycystic ovarian syndrome and its health effects, in reproductive age women (15-45 years) in a rural area, Telangana, India

Yoga Effects on Anthropometric Indices and Polycystic Ovary Syndrome Symptoms in Women Undergoing Infertility Treatment: A Randomized Controlled Clinical Trial

Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women

Contact Info

Product

Resources

About